ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGL Angle Plc

14.50
0.50 (3.57%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 3.57% 14.50 14.00 15.00 15.00 14.00 14.00 1,310,616 10:04:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 1.04M -21.69M -0.0832 -1.74 37.78M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 14p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £37.78 million. Angle has a price to earnings ratio (PE ratio) of -1.74.

Angle Share Discussion Threads

Showing 32051 to 32072 of 32675 messages
Chat Pages: Latest  1283  1282  1281  1280  1279  1278  1277  1276  1275  1274  1273  1272  Older
DateSubjectAuthorDiscuss
14/3/2024
08:37
“Time to move on” indeed Bones. If I valued a share at 4p and could sell for 14.75p I’d definitely move on, as opposed to coming on every couple of days saying they’ll be a raise.
adw198
14/3/2024
08:20
You’re giving her too much credit amt.

Don't be daft, Bones can’t read 🤣

paul planet earth 1
14/3/2024
07:35
Lies, lies, and more dammed lies!
bones699
14/3/2024
07:34
What nonsense Bones, why don't you read the updates which clearly state the extension of the cash runway to Q2 2025
amt
14/3/2024
07:32
Think I have more chance of spotting a unicorn walking down Croydons high street than this tu@d of a share ever turning into a pearl overnight...

An inevitable cash raise on the horizon and having held for over 10 years at 40p think that's just chucking money down the u bend!

No commercial deals and an unapproved product good for only testing 4% of cancers, that no ones wants, and down £130m to date sums it all up...the 'King Dog Tu@d' of all shares with a compulsive lying CEO at the helm, typical AIM stock, time to move on!

bones699
12/3/2024
21:23
Cash must be down to I reckon £7m now burning through over a £1m a month can't last long...Looking forward to Newlands 'strategic'initiatives kicking in as eluded to during the recent Investor Meet...wonder what they are...skint...need cash...kitty almost empty...I know retail mugs like Zeus19 can bail us out lol!
bones699
12/3/2024
21:21
Yup definitely on the cards...but at what price?
bones699
12/3/2024
19:40
I hear a placing is on the way.
havinthelasttoast
12/3/2024
18:06
Seems nobody wants our Parsortix machines sales to date zero! ..😟😩😫😓
bones699
12/3/2024
18:05
13p placing is that for the whole firm seems generous wouldn't give 3p for this utter cr@p!
bones699
12/3/2024
16:05
Right back on resistance level again.

Strong BUY for the next bounce.


....or TAKEOVER

philjeans
12/3/2024
11:21
Looks like youre doing the rounds with your placing comments
zeus19
12/3/2024
10:54
Placing 13p
beatme1
12/3/2024
10:28
Looking like a rally coming here
kirk 6
12/3/2024
09:38
As less than 20% of shares are declared held above 3%...it makes one wonder where all those traded shares over the last few months, have gone...
Curious...anyone come across any Funds / Investment Trusts that have an AGL holding...?

sawney
11/3/2024
20:25
Thank you both for the feedback. I am pleased for your mate Goose and for sure, he is a classic example of the need!
Let’s look forward to a successful outcome.

digger18
11/3/2024
20:14
Great and thought provoking post Gooosed.

As IG said to me after the presentation, it’s about getting the best results from the samples. It is important they identify the optimal processes for doing this.

The company has now brought the Illumina & Thermo Fisher NGS platforms “in house”. They had previously outsourced the samples for analysis but, according to IG, the BiDetect results were so good they brought the kits in house Dec 2023/Jan 2024. Hopefully this will help expedite future analysis of the samples.

radderssandy
11/3/2024
19:38
digger18 - I suspect there are more than a few that share your disappointment but that are equally appreciative of some of the posters here - amongst so much repetitive dross.

A close buddy of mine lost his wife a few years ago. A few months later he was diagnosed with Prostate cancer. He had the SoC biopsy which resulted in him being rendered impotent. The treatment however, despite what his consultant described as a serious case, was (touch wood) successful.
He went on to meet (six months into the pandemic) a lovely lady who made him happy & was able to see beyond the obvious physical consequences of the prostatectomy.

The difference that a simple non-invasive (repeatable) blood draw would have made is immeasurable.

Solaris Healthcare have thus far added, by my reckoning a further 175,000 patients to their client base since embarking on the collaborative trial with Angle. That's 900,000 patients/annum for whom a simple, repeatable & non-invasive procedure may be the difference between life & death and a continuing quality of life.

The fact as alluded to by Raddersandy, that Solaris appear happy to wait for the process to unfold - imho, speaks volumes.

gooosed
11/3/2024
18:13
Thank you radders, I guess that all makes sense but just disappointing that the time lines have slipped. However, I have confidence that they will get it right and hopefully this could lead to a game changer for diagnostic albeit time delayed through a Solaris lab.
digger18
11/3/2024
09:38
radders,

Another useful, informative and balanced post. Thanks - much appreciated.

bermudashorts
11/3/2024
09:21
I agree Boris, so end April with final results.
fhmktg
11/3/2024
08:47
Anyone who can't except timelines and targets will slip when it comes to biotevh and biopharma Co's would probably be better off infesting in utilities....

Having said that the Co. should always keep investors up to date as best they can.

boris cobaka
Chat Pages: Latest  1283  1282  1281  1280  1279  1278  1277  1276  1275  1274  1273  1272  Older

Your Recent History

Delayed Upgrade Clock